UCB (UCB)

Index:

BEL 20

  245.98
   
  • Change Today:
     -0.42
  • 52 Week High:  260.20
  • 52 Week Low:  129.35
  • Currency: Euro
  • Shares Issued: 190.00m
  • Volume: 11,961
  • Market Cap:  46,736m
  • Beta: 1.81

Latest ShareCast News

Belgium's UCB to buy US-based Ra Pharmaceuticals for $2.1bn

By Michele Maatouk

Date: Thursday 10 Oct 2019

(Sharecast News) - Belgian drug maker UCB has agreed to buy US-based clinical-stage biopharmaceuticals company Ra Pharmaceuticals for $2.1bn.

UCB ShareCast News

No recent information was found.

UCB Newspaper Links

GSK gets emerging markets boost with UCB deal 24-Jan-2009 Telegraph
UCB confident on drug go-ahead 21-Aug-2007 The Scotsman
Fellner shuffles Acambis board 08-Mar-2007 Telegraph
Deal speeds drugs sector consolidation 26-Sep-2006 The Herald

UCB Tips & Analysis

No recent information was found.

UCB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

UCB Market Data

Currency Euro
Share Price   245.98
Change Today   -0.42
% Change -0.17 %
52 Week High  260.20
52 Week Low  129.35
Volume 11,961
Shares Issued 190.00m
Market Cap  46,736m
Beta 1.81

What The Brokers Say

Strong Buy 7
Buy 11
Neutral 3
Sell 0
Strong Sell 0
Total 21
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 24-Oct-2025

Time Volume / Share Price
12:04 2 @  245.90
12:04 7 @  245.90
12:02 8 @  245.90
12:00 13 @  246.00
12:00 91 @  246.00

Top of Page